Home » Topics » BioWorld Science

BioWorld Science
RSS

Safety characterization of a sapM mutated-BCG vaccine

Sep. 30, 2019

New TRPC5 modulators patented by Goldfinch Biopharma

Sep. 30, 2019

Novel near-infrared probe of biliary anatomy for image-guided hepatic surgery

Sep. 30, 2019

Bristol-Myers Squibb synthesizes hSTING agonists

Sep. 30, 2019

Development and characterization of IRAK-4 inhibitors

Sep. 30, 2019

Southwest Research Institute patent details agents for filovirus infection

Sep. 30, 2019

Medivir discloses nucleoside analogues for leukemia

Sep. 30, 2019

Arcus Biosciences divulges ARG1 and ARG2 inhibitors

Sep. 30, 2019

Phase IIa data support S-600918 as promising option for refractory chronic cough

Sep. 30, 2019

Zoliflodacin begins pivotal phase III trial for treatment of gonorrhea

Sep. 30, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Beone eyes Huahui Health’s trispecific HH-160 with $2B option deal
BioWorld
Beone Medicines Ltd. gained an exclusive option to develop cancer immunotherapy HH-160 worldwide in a deal potentially worth more than $2 billion for Huahui...
Unique trial strategy muddies the ODAC waters for camizestrant
BioWorld
Following a discussion that focused more on a new personalized trial strategy rather than the proposed therapy, the U.S. FDA’s Oncologic Drugs Advisory Committee...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...